Due to mutations in APP and genetic risk genes, such as PSEN1 and PSEN2 which alter amyloid concentrations, patients with DS are more prone to develop Alzheimer’s disease at an earlier age (30–60 years) than those with late-onset Alzheimer’s disease (≥65 years) [122]. Here, PSEN1 is linked to Alzheimer disease.